D K Luscombe
About
In The Last Decade
D K Luscombe
43 papers receiving 848 citations
Peers
Comparison fields: 5 of 116
- Dermatology 296
- Immunology 221
- Economics and Econometrics 132
- Immunology and Allergy 108
- Psychiatry and Mental health 98
Countries citing papers authored by D K Luscombe
This map shows the geographic impact of D K Luscombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D K Luscombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D K Luscombe more than expected).
Fields of papers citing papers by D K Luscombe
This network shows the impact of papers produced by D K Luscombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D K Luscombe. The network helps show where D K Luscombe may publish in the future.
Co-authorship network of co-authors of D K Luscombe
This figure shows the co-authorship network connecting the top 25 collaborators of D K Luscombe. A scholar is included among the top collaborators of D K Luscombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D K Luscombe. D K Luscombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Symptom or adverse drug reaction? An investigation into how symptoms are recognised as side-effects of medication | 3 |
| 2 | 18 | |
| 3 | 52 | |
| 4 | 35 | |
| 5 | 19 | |
| 6 | 78 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 7 | |
| 10 | 257 | |
| 11 | 5 | |
| 12 | 2 | |
| 13 | Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis. | 22 |
| 14 | 1 | |
| 15 | Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis. | 1 |
| 16 | 5 | |
| 17 | Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil). | 7 |
| 18 | Absorption, elimination and duration of action of diethyldithiocarbamate in animals [proceedings]. | 1 |
| 19 | Plasma levels of clomipramine and its N-desmethyl metabolite following oral administration of clomipramine in man [proceedings]. | 8 |
| 20 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.